Role of the intestinal microbiota in sepsis-associated encephalopathy

Abstract

Sepsis-associated encephalopathy (SAE) is a secondary cerebral dysfunction of the central nervous system (CNS) caused by sepsis and is associated with high mortality rate and poor prognosis. It significantly affects the quality of life of survivors. The pathological mechanisms associated with SAE include dysfunction of the blood–brain barrier (BBB), activation of glial cells, ischemic injury, leukocyte transmigration, and disturbances in neurotransmitters. The mechanisms of SAE interact with and contribute to its development. Numerous studies have demonstrated that the intestinal microbiota affects not only the health of the gut but also that of other organs. Throughout the progression of SAE, alterations in the gut microbiome composition lead to the production of toxic substances that damage the intestinal barrier and enter the bloodstream. This damage negatively affects BBB permeability and initiates a cascade of neuroinflammatory responses that result in neuronal injury. Conversely, specific microbiome-derived derivatives play exhibit a neuroprotective role in regulating brain function. Therefore, gut–brain crosstalk may be a crucial factor in brain dysfunction. This paper reviews the relationship between the intestinal microbiota and SAE, aiming to explore the role of the intestinal microbiota in SAE and potential therapeutic targets.

Keywords

Sepsis-associated encephalopathy / microbiota dysbiosis / bacterial translocation / microbiota theraputic

References

[1] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801-10. https://doi.org/10.1001/jama.2016.0287.

[2] Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 2016; 193:259-72. https://doi.org/10.1164/rccm.201504-0781OC.

[3] Mazeraud A, Pascal Q, Verdonk F, Heming N, Chretien F, Sharshar T. Neuroanatomy and physiology of brain dysfunction in sepsis. Clin Chest Med 2016; 37:333-45. https://doi.org/10.1016/j.ccm.2016.01.013.

[4] Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics 2020; 17:392-403. https://doi.org/10.1007/s13311-020-00862-1.

[5] Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361:512-9. https://doi.org/10.1016/S0140-6736(03)12489-0.

[6] Singer BH, Dickson RP, Denstaedt SJ, Newstead MW, Kim K, Falkowski NR, et al. Bacterial dissemination to the brain in sepsis. Am J Respir Crit Care Med 2018; 197:747-56. https://doi.org/10.1164/rccm.201708-1559OC.

[7] Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol 2020; 19:179-94. https://doi.org/10.1016/S1474-4422(19)30356-4.

[8] Fang H, Wang Y, Deng J, Zhang H, Wu Q, He L, et al. Sepsis-induced gut dysbiosis mediates the susceptibility to sepsis-associated encephalopathy in mice. mSystems 2022; 7:e0139921. https://doi.org/10.1128/msystems.01399-21.

[9] Zhang H, Xu J, Wu Q, Fang H, Shao X, Ouyang X, et al. Gut microbiota mediates the susceptibility of mice to sepsis-associated encephalopathy by butyric acid. J Inflamm Res 2022; 15:2103-19. https://doi.org/10.2147/JIR.S350566.

[10] Segawa S, Fujiya M, Konishi H, Ueno N, Kobayashi N, Shigyo T, et al. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS One 2011; 6:e23278. https://doi.org/10.1371/journal.pone.0023278.

[11] Liao H, Li H, Bao H, Jiang L, Du J, Guo Y, et al. Short chain fatty acids protect the cognitive function of sepsis associated encephalopathy mice via GPR43. Front Neurol 2022; 13:909436. https://doi.org/10.3389/fneur.2022.909436.

[12] Kaplan L, Chow BW, Gu C. Neuronal regulation of the blood-brain barrier and neurovascular coupling. Nat Rev Neurosci 2020; 21:416-32. https://doi.org/10.1038/s41583-020-0322-2.

[13] Erickson MA, Banks WA. Neuroimmune axes of the blood-brain barriers and blood-brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev 2018; 70:278-314. https://doi.org/10.1124/pr.117.014647.

[14] Nwafor DC, Brichacek AL, Mohammad AS, Griffith J, Lucke-Wold BP, Benkovic SA, et al. Targeting the blood-brain barrier to prevent sepsis-associated cognitive impairment. J Cent Nerv Syst Dis 2019; 11:1179573519840652. https://doi.org/10.1177/1179573519840652.

[15] Peng X, Luo Z, He S, Zhang L, Li Y. Blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy. Front Cell Infect Microbiol 2021; 11:768108. https://doi.org/10.3389/fcimb.2021.768108.

[16] Ni Y, Teng T, Li R, Simonyi A, Sun GY, Lee JC. TNF-alpha alters occludin and cerebral endothelial permeability: role of p38MAPK. PLoS One 2017; 12:e0170346. https://doi.org/10.1371/journal.pone.0170346.

[17] Danielski LG, Giustina AD, Goldim MP, Florentino D, Mathias K, Garbossa L, et al. Vitamin B(6) reduces neurochemical and long-term cognitive alterations after polymicrobial sepsis: involvement of the kynurenine pathway modulation. Mol Neurobiol 2018; 55:5255-68. https://doi.org/10.1007/s12035-017-0706-0.

[18] Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 2001; 50:812-21. https://doi.org/10.1099/0022-1317-50-9-812.

[19] Mina F, Comim CM, Dominguini D, Cassol OJ Jr, Dall Igna DM, Ferreira GK, et al. Il1-beta involvement in cognitive impairment after sepsis. Mol Neurobiol 2014; 49:1069-76. https://doi.org/10.1007/s12035-013-8581-9.

[20] Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G. The neuropathology of septic shock. Brain Pathol 2004; 14:21-33. https://doi.org/10.1111/j.1750-3639.2004.tb00494.x.

[21] Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003; 362:1799-805. https://doi.org/10.1016/S0140-6736(03)14899-4.

[22] Chuang YC, Tsai JL, Chang AY, Chan JY, Liou CW, Chan SH. Dysfunction of the mitochondrial respiratory chain in the rostral ventrolateral medulla during experimental endotoxemia in the rat. J Biomed Sci 2002; 9:542-8. https://doi.org/10.1007/BF02254981.

[23] Duport S, Garthwaite J. Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures. Neuroscience 2005; 135:1155-66. https://doi.org/10.1016/j.neuroscience.2005.06.035.

[24] Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ . TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int 2008; 52:447-56. https://doi.org/10.1016/j.neuint.2007.08.006.

[25] Hasegawa-Ishii S, Inaba M, Umegaki H, Unno K, Wakabayashi K, Shimada A. Endotoxemia-induced cytokine-mediated responses of hippocampal astrocytes transmitted by cells of the brain-immune interface. Sci Rep 2016; 6:25457. https://doi.org/10.1038/srep25457.

[26] Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia 2015; 63:2274-84. https://doi.org/10.1002/glia.22892.

[27] Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4:702-10. https://doi.org/10.1038/89490.

[28] Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017; 541:481-7. https://doi.org/10.1038/nature21029.

[29] Taccone FS, Su F, Pierrakos C, He X, James S, Dewitte O, et al. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit Care 2010; 14:R140. https://doi.org/10.1186/cc9205.

[30] Taccone FS, Su F, De Deyne C, Abdellhai A, Pierrakos C, He X, et al. Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis. Crit Care Med 2014; 42:e114-22. https://doi.org/10.1097/CCM.0b013e3182a641b8.

[31] Ostergaard L, Engedal TS, Aamand R, Mikkelsen R, Iversen NK, Anzabi M, et al. Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury. J Cereb Blood Flow Metab 2014; 34:1585-98. https://doi.org/10.1038/jcbfm.2014.131.

[32] Bordoni L, Thoren AE, Gutierrez-Jimenez E, Abjorsbraten KS, Bjornstad DM, Tang W, et al. Deletion of aquaporin-4 improves capillary blood flow distribution in brain edema. Glia 2023; 71:2559-72. https://doi.org/10.1002/glia.24439.

[33] Michinaga S, Koyama Y. Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci 2015; 16:9949-75. https://doi.org/10.3390/ijms16059949.

[34] Liang D, Bhatta S, Gerzanich V, Simard JM. Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg Focus 2007; 22:1-9. https://doi.org/10.3171/foc.2007.22.5.3.

[35] Andonegui G, Zelinski EL, Schubert CL, Knight D, Craig LA, Winston BW, et al. Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment. JCI Insight 2018; 3:e99364. https://doi.org/10.1172/jci.insight.99364.

[36] Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong CH, Petri B, et al. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J Exp Med 2015; 212:447-56. https://doi.org/10.1084/jem.20141539.

[37] Kenne E, Erlandsson A, Lindbom L, Hillered L, Clausen F. Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. J Neuroinflammation 2012; 9:17. https://doi.org/10.1186/1742-2094-9-17.

[38] Margraf A, Ley K, Zarbock A. Neutrophil recruitment: from model systems to tissue-specific patterns. Trends Immunol 2019; 40:613-34. https://doi.org/10.1016/j.it.2019.04.010.

[39] Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH. Recruitment of neutrophils across the blood-brain barrier: the role of E-and P-selectins. J Cereb Blood Flow Metab 2001; 21:1115-24. https://doi.org/10.1097/00004647-200109000-00009.

[40] Zhou H, Andonegui G, Wong CH, Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J Immunol 2009; 183:5244-50. https://doi.org/10.4049/jimmunol.0901309.

[41] Wu F, Chen X, Zhai L, Wang H, Sun M, Song C, et al. CXCR2 antagonist attenuates neutrophil transmigration into brain in a murine model of LPS induced neuroinflammation. Biochem Biophys Res Commun 2020; 529:839-45. https://doi.org/10.1016/j.bbrc.2020.05.124.

[42] Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994; 145:189-201.

[43] Neumann J, Riek-Burchardt M, Herz J, Doeppner TR, Konig R, Hutten H, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol 2015; 129:259-77. https://doi.org/10.1007/s00401-014-1355-2.

[44] Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and Hemorrhagic transformation following ischemic stroke. Front Cell Neurosci 2016; 10:56.

[45] Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005; 289:H558-68. https://doi.org/10.1152/ajpheart.01275.2004.

[46] Gao YL, Liu YC, Zhang X, Shou ST, Chai YF. Insight into regulatory T cells in sepsis-associated encephalopathy. Front Neurol 2022; 13:830784. https://doi.org/10.3389/fneur.2022.830784.

[47] Wang SC, Su KP, Pariante CM. The three frontlines against COVID-19: brain, behavior, and immunity. Brain Behav Immun 2021; 93:409-14. https://doi.org/10.1016/j.bbi.2021.01.030.

[48] Serantes R, Arnalich F, Figueroa M, Salinas M, Andres-Mateos E, Codoceo R, et al. Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem 2006; 281:14632-43. https://doi.org/10.1074/jbc.M512489200.

[49] Zong MM, Zhou ZQ, Ji MH, Jia M, Tang H, Yang JJ. Activation of beta2-adrenoceptor attenuates sepsis-induced hippocampus-dependent cognitive impairments by reversing neuroinflammation and synaptic abnormalities. Front Cell Neurosci 2019; 13:293. https://doi.org/10.3389/fncel.2019.00293.

[50] Zaghloul N, Addorisio ME, Silverman HA, Patel HL, Valdes-Ferrer SI, Ayasolla KR, et al. Forebrain cholinergic dysfunction and systemic and brain inflammation in murine sepsis survivors. Front Immunol 2017; 8:1673. https://doi.org/10.3389/fimmu.2017.01673.

[51] Santos-Junior NN, Catalao CHR, Costa LHA, Souza AO, Mota CMD, Alberici LC, et al. Experimental sepsis induces sustained inflammation and acetylcholinesterase activity impairment in the hypothalamus. J Neuroimmunol 2018; 324:143-8. https://doi.org/10.1016/j.jneuroim.2018.08.013.

[52] Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008; 36:404-8. https://doi.org/10.1097/01.CCM.0B013E31816208B3.

[53] Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, et al. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 2008; 203:12-22. https://doi.org/10.1016/j.jneuroim.2008.06.018.

[54] Sommer BR, Wise LC, Kraemer HC. Is dopamine administration possibly a risk factor for delirium? Crit Care Med 2002; 30:1508-11. https://doi.org/10.1097/00003246-200207000-00019.

[55] Li F, Zhang B, Duan S, Qing W, Tan L, Chen S, et al. Small dose of L-dopa/Benserazide hydrochloride improved sepsis-induced neuroinflammation and long-term cognitive dysfunction in sepsis mice. Brain Res 2020; 1737:146780. https://doi.org/10.1016/j.brainres.2020.146780.

[56] Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-20. https://doi.org/10.1126/science.1104816.

[57] Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837-48. https://doi.org/10.1016/j.cell.2006.02.017.

[58] Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Biores Open Access 2012; 1:192-8. https://doi.org/10.1089/biores.2012.0223.

[59] Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 2015; 17:662-71. https://doi.org/10.1016/j.chom.2015.03.005.

[60] Litvak Y, Byndloss MX, Baumler AJ. Colonocyte metabolism shapes the gut microbiota. Science 2018; 362:eaat9076. https://doi.org/10.1126/science.aat9076.

[61] Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504:446-50. https://doi.org/10.1038/nature12721.

[62] Byndloss MX, Olsan EE, Rivera-Chavez F, Tiffany CR, Cevallos SA, Lokken KL, et al. Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 2017; 357:570-5. https://doi.org/10.1126/science.aam9949.

[63] Byndloss MX, Baumler AJ. The germ-organ theory of non-communicable diseases. Nat Rev Microbiol 2018; 16:103-10. https://doi.org/10.1038/nrmicro.2017.158.

[64] Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, et al. Helicobacter pylori infection is associated with worse severity of Parkinson’s disease. Parkinsonism Relat Disord 2015; 21:221-5. https://doi.org/10.1016/j.parkreldis.2014.12.009.

[65] Pierantozzi M, Pietroiusti A, Sancesario G, Lunardi G, Fedele E, Giacomini P, et al. Reduced L-dopa absorption and increased clinical fluctuations in helicobacter pylori-infected Parkinson’s disease patients. Neurol Sci 2001; 22:89-91. https://doi.org/10.1007/s100720170061.

[66] Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, et al. Colonic bacterial composition in Parkinson’s disease. Mov Disord 2015; 30:1351-60. https://doi.org/10.1002/mds.26307.

[67] Hopfner F, Kunstner A, Muller SH, Kunzel S, Zeuner KE, Margraf NG, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 2017; 1667:41-5. https://doi.org/10.1016/j.brainres.2017.04.019.

[68] Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 2015; 30:350-8. https://doi.org/10.1002/mds.26069.

[69] Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 2017; 49:60-8. https://doi.org/10.1016/j.neurobiolaging.2016.08.019.

[70] Xi J, Ding D, Zhu H, Wang R, Su F, Wu W, et al. Disturbed microbial ecology in Alzheimer’s disease: evidence from the gut microbiota and fecal metabolome. BMC Microbiol 2021; 21:226. https://doi.org/10.1186/s12866-021-02286-z.

[71] Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep 2017; 7:13537. https://doi.org/10.1038/s41598-017-13601-y.

[72] Asti A, Gioglio L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J Alzheimer’s Dis 2014; 39:169-79. https://doi.org/10.3233/JAD-131394.

[73] Romond MB, Colavizza M, Mullie C, Kalach N, Kremp O, Mielcarek C, et al. Does the intestinal bifidobacterial colonisation affect bacterial translocation? Anaerobe 2008; 14:43-8. https://doi.org/10.1016/j.anaerobe.2007.09.003.

[74] Ochoa CD, Alexeyev M, Pastukh V, Balczon R, Stevens T. Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability. J Biol Chem 2012; 287:25407-18. https://doi.org/10.1074/jbc.M111.301440.

[75] Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105:16731-6. https://doi.org/10.1073/pnas.0804812105.

[76] Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE, et al. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol 2010; 184:5333-43. https://doi.org/10.4049/jimmunol.0903382.

[77] Chi L, Mahbub R, Gao B, Bian X, Tu P, Ru H, et al. Nicotine alters the gut microbiome and metabolites of gut-brain interactions in a sex-specific manner. Chem Res Toxicol 2017; 30:2110-9. https://doi.org/10.1021/acs.chemrestox.7b00162.

[78] Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res 2015; 77:229-35. https://doi.org/10.1038/pr.2014.156.

[79] Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 2006; 61:650-7. https://doi.org/10.1097/01.ta.0000196574.70614.27.

[80] Xu K, Gao X, Xia G, Chen M, Zeng N, Wang S, et al. Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. Gut 2021; 70:1486-94. https://doi.org/10.1136/gutjnl-2020-323263.

[81] Neville BA, Forde BM, Claesson MJ, Darby T, Coghlan A, Nally K, et al. Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile Lactobacilli. PLoS One 2012; 7:e40592. https://doi.org/10.1371/journal.pone.0040592.

[82] Yamashiro K, Tanaka R, Urabe T, Ueno Y, Yamashiro Y, Nomoto K, et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One 2017; 12:e0171521. https://doi.org/10.1371/journal.pone.0171521.

[83] Houlden A, Goldrick M, Brough D, Vizi ES, Lenart N, Martinecz B, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun 2016; 57:10-20. https://doi.org/10.1016/j.bbi.2016.04.003.

[84] Wu W, Sun Y, Luo N, Cheng C, Jiang C, Yu Q, et al. Integrated 16S rRNA gene sequencing and LC-MS analysis revealed the interplay between gut microbiota and plasma metabolites in rats with ischemic stroke. J Mol Neurosci 2021; 71:2095-106. https://doi.org/10.1007/s12031-021-01828-4.

[85] Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 2015; 4:e002699. https://doi.org/10.1161/JAHA.115.002699.

[86] Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 2015; 33:496-503. https://doi.org/10.1016/j.tibtech.2015.06.011.

[87] Devriese S, Eeckhaut V, Geirnaert A, Van den Bossche L, Hindryckx P, Van de Wiele T, et al. Reduced mucosa-associated Butyricicoccus activity in patients with ulcerative colitis correlates with aberrant Claudin-1 expression. J Crohns Colitis 2017; 11:229-36. https://doi.org/10.1093/ecco-jcc/jjw142.

[88] Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 2011; 331:337-41. https://doi.org/10.1126/science.1198469.

[89] Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA 2017; 114:10713-8. https://doi.org/10.1073/pnas.1711235114.

[90] Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, et al. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol 2016; 23:1308-21. https://doi.org/10.1111/ene.13026.

[91] Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells. PLoS One 2014; 9:e99411. https://doi.org/10.1371/journal.pone.0099411.

[92] Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol 2018; 83:1147-61. https://doi.org/10.1002/ana.25244.

[93] Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 2016; 7:12015. https://doi.org/10.1038/ncomms12015.

[94] Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17:1519-28. https://doi.org/10.3748/wjg.v17.i12.1519.

[95] Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6:28484. https://doi.org/10.1038/srep28484.

[96] Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 2009; 183:6251-61. https://doi.org/10.4049/jimmunol.0803978.

[97] Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010; 185:4101-8. https://doi.org/10.4049/jimmunol.1001443.

[98] Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One 2015; 10:e0137429. https://doi.org/10.1371/journal.pone.0137429.

[99] Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 2015; 63:729-34. https://doi.org/10.1097/JIM.0000000000000192.

[100] Wang H, Wang Q, Chen J, Chen C. Association among the gut microbiome, the serum metabolomic profile and RNA m(6)a methylation in sepsis-associated encephalopathy. Front Genet 2022; 13:859727. https://doi.org/10.3389/fgene.2022.859727.

[101] Li S, Lv J, Li J, Zhao Z, Guo H, Zhang Y, et al. Intestinal microbiota impact sepsis associated encephalopathy via the vagus nerve. Neurosci Lett 2018; 662:98-104. https://doi.org/10.1016/j.neulet.2017.10.008.

[102] Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, et al. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med 2019; 216:84-98. https://doi.org/10.1084/jem.20181639.

[103] Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2012; 302:G168-75. https://doi.org/10.1152/ajpgi.00190.2011.

[104] Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303:G675-85. https://doi.org/10.1152/ajpgi.00152.2012.

[105] Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, et al. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol 2013; 108:1601-11. https://doi.org/10.1038/ajg.2013.221.

[106] Quigley EMM. Microbiota-brain-gut Axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 2017; 17:94. https://doi.org/10.1007/s11910-017-0802-6.

[107] Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J Neurosci 2016; 36:7428-40. https://doi.org/10.1523/JNEUROSCI.1114-16.2016.

[108] Hu W, Kong X, Wang H, Li Y, Luo Y. Ischemic stroke and intestinal flora: an insight into brain-gut axis. Eur J Med Res 2022; 27:73. https://doi.org/10.1186/s40001-022-00691-2.

[109] Holte K, Krag A, Gluud LL. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatol Res 2012; 42:1008-15. https://doi.org/10.1111/j.1872-034X.2012.01015.x.

[110] Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol 2014; 12:1003-1008 e1001. https://doi.org/10.1016/j.cgh.2013.11.006.

[111] Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39:1441-9. https://doi.org/10.1002/hep.20194.

[112] Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33:662-71. https://doi.org/10.1111/j.1365-2036.2010.04574.x.

[113] Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, et al. Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 2016; 6:e774. https://doi.org/10.1038/tp.2016.42.

[114] Libbey JE, Sanchez JM, Doty DJ, Sim JT, Cusick MF, Cox JE, et al. Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model. Benef Microbes 2018; 9:495-513.

[115] Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014; 6:263ra158. https://doi.org/10.1126/scitranslmed.3009759.

[116] Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 2014; 5:3611. https://doi.org/10.1038/ncomms4611.

[117] Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis 2012; 23:19260. https://doi.org/10.3402/mehd.v23i0.19260.

[118] Wang X, Wen X, Yuan S, Zhang J. Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy. Neurobiol Dis 2024; 195:106499. https://doi.org/10.1016/j.nbd.2024.106499.

[119] Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, et al. The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Crit Care 2020; 24:278. https://doi.org/10.1186/s13054-020-02989-1.

[120] Woodworth MH, Hayden MK, Young VB, Kwon JH. The role of fecal microbiota transplantation in reducing intestinal colonization with antibiotic-resistant organisms: the current landscape and future directions. Open Forum Infect Dis 2019;6:6. https://doi.org/10.1093/ofid/ofz391.

[121] Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med 2015; 192:581-8. https://doi.org/10.1164/rccm.201503-0483OC.

[122] Han L, Jin H, Zhou L, Zhang X, Fan Z, Dai M, et al. Intestinal microbiota at engraftment influence acute graft-versus-host disease via the Treg/Th17 balance in Allo-HSCT recipients. Front Immunol 2018; 9:669. https://doi.org/10.3389/fimmu.2018.00669.

[123] Mikawa S, Ohta Y, Kaji N, Islam MS, Murata T, Ozaki H, et al. Time-dependent changes in inhibitory action of lipopolysaccharide on intestinal motility in rat. J Vet Med Sci 2015; 77:1443-9. https://doi.org/10.1292/jvms.15-0198.

[124] Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Phys 1999; 277:G478-86. https://doi.org/10.1152/ajpgi.1999.277.2.G478.

[125] Faber F, Tran L, Byndloss MX, Lopez CA, Velazquez EM, Kerrinnes T, et al. Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. Nature 2016; 534:697-9. https://doi.org/10.1038/nature18597.

[126] Liu J, Peng R, Tan Q, Li B, Chen J, Liu G, et al. Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea. PLoS One 2022; 17:e0273853. https://doi.org/10.1371/journal.pone.0273853.

[127] Lopez CA, Miller BM, Rivera-Chavez F, Velazquez EM, Byndloss MX, Chavez-Arroyo A, et al. Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration. Science 2016; 353:1249-53. https://doi.org/10.1126/science.aag3042.

[128] Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol 2016; 13:517-28. https://doi.org/10.1038/nrgastro.2016.107.

[129] Tieu K. A guide to neurotoxic animal models of Parkinson’s disease. Cold Spring Harb Perspect Med 2011; 1:a009316. https://doi.org/10.1101/cshperspect.a009316.

[130] Wu Q, Zhang Y, Zhang Y, Xia C, Lai Q, Dong Z, et al. Potential effects of antibiotic-induced gut microbiome alteration on blood-brain barrier permeability compromise in rhesus monkeys. Ann N Y Acad Sci 2020; 1470:14-24. https://doi.org/10.1111/nyas.14312.

[131] Leclercq S, Mian FM, Stanisz AM, Bindels LB, Cambier E, Ben-Amram H, et al. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat Commun 2017; 8:15062. https://doi.org/10.1038/ncomms15062.

[132] Boveri M, Kinsner A, Berezowski V, Lenfant AM, Draing C, Cecchelli R, et al. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 2006; 137:1193-209. https://doi.org/10.1016/j.neuroscience.2005.10.011.

[133] Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Hasko J, et al. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem Int 2010; 57:556-64. https://doi.org/10.1016/j.neuint.2010.07.002.

[134] Soult MC, Lonergan NE, Shah B, Kim WK, Britt LD, Sullivan CJ. Outer membrane vesicles from pathogenic bacteria initiate an inflammatory response in human endothelial cells. J Surg Res 2013; 184:458-66. https://doi.org/10.1016/j.jss.2013.05.035.

[135] Gurney KJ, Estrada EY, Rosenberg GA. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 2006; 23:87-96. https://doi.org/10.1016/j.nbd.2006.02.006.

[136] Mun-Bryce S, Lukes A, Wallace J, Lukes-Marx M, Rosenberg GA. Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res 2002; 933:42-9. https://doi.org/10.1016/S0006-8993(02)02303-X.

[137] Liu J, Jin Y, Ye Y, Tang Y, Dai S, Li M, et al. The neuroprotective effect of short chain fatty acids against sepsis-associated encephalopathy in mice. Front Immunol 2021; 12:626894. https://doi.org/10.3389/fimmu.2021.626894.

[138] Hwang IK, Yoo KY, Li H, Park OK, Lee CH, Choi JH, et al. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J Neurosci Res 2009; 87:2126-37. https://doi.org/10.1002/jnr.22030.

[139] Huang ZB, Zhang GP, Lu CX, Gong C, Gao X, Lin Y, et al. Gut microbiota-derived 3-indoleacetic acid confers a protection against sepsis-associated encephalopathy through microglial aryl hydrocarbon receptors. Exp Neurol 2025; 384:115055. https://doi.org/10.1016/j.expneurol.2024.115055.

[140] Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010; 10:316. https://doi.org/10.1186/1471-2180-10-316.

[141] Bulacios GA, Cataldo PG, Naja JR, de Chaves EP, Taranto MP, Minahk CJ, et al. Improvement of key molecular events linked to Alzheimer’s disease pathology using postbiotics. ACS Omega 2023; 8:48042-9. https://doi.org/10.1021/acsomega.3c06805.

[142] Hwang JH, Wu SJ, Wu PL, Shih YY, Chan YC. Neuroprotective effect of tempeh against lipopolysaccharide-induced damage in BV-2 microglial cells. Nutr Neurosci 2019; 22:840-9. https://doi.org/10.1080/1028415X.2018.1456040.

[143] Logiacco F, Xia P, Georgiev SV, Franconi C, Chang YJ, Ugursu B, et al. Microglia sense neuronal activity via GABA in the early postnatal hippocampus. Cell Rep 2021; 37:110128. https://doi.org/10.1016/j.celrep.2021.110128.

[144] Liu J, Jin Y, Li H, Yu J, Gong T, Gao X, et al. Probiotics exert protective effect against sepsis-induced cognitive impairment by reversing gut microbiota abnormalities. J Agric Food Chem 2020; 68:14874-83. https://doi.org/10.1021/acs.jafc.0c06332.

[145] Akira S, Hemmi H . Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85:85-95. https://doi.org/10.1016/S0165-2478(02)00228-6.

[146] Erny D, Hrabe de Angelis AL, Prinz M. Communicating systems in the body: how microbiota and microglia cooperate. Immunology 2017; 150:7-15. https://doi.org/10.1111/imm.12645.

[147] Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18:965-77. https://doi.org/10.1038/nn.4030.

[148] Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, et al. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J 2013; 27:1176-90. https://doi.org/10.1096/fj.12-222257.

[149] Zhang ZX, Peng J, Ding WW. Lipocalin-2 and intestinal diseases. World J Gastroenterol 2024; 30:4864-79. https://doi.org/10.3748/wjg.v30.i46.4864.

[150] Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 2016; 167:1469-1480 e1412. https://doi.org/10.1016/j.cell.2016.11.018.

[151] Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996; 14:301-31. https://doi.org/10.1146/annurev.immunol.14.1.301.

[152] Mack CL, Vanderlugt-Castaneda CL, Neville KL, Miller SD. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler’s virus model of multiple sclerosis. J Neuroimmunol 2003; 144:68-79. https://doi.org/10.1016/j.jneuroim.2003.08.032.

[153] Lukiw WJ. Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease. Front Microbiol 2016; 7:1544. https://doi.org/10.3389/fmicb.2016.01544.

[154] Sanmarco LM, Wheeler MA, Gutierrez-Vazquez C, Polonio CM, Linnerbauer M, Pinho-Ribeiro FA, et al. Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature 2021; 590:473-9. https://doi.org/10.1038/s41586-020-03116-4.

[155] Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586-97. https://doi.org/10.1038/nm.4106.

[156] Michel LV, Gaborski T. Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: taking advantage of nature’s perfect packages. J Biol Chem 2022; 298:102483. https://doi.org/10.1016/j.jbc.2022.102483.

[157] Jan AT. Outer membrane vesicles (OMVs) of gram-negative bacteria: a perspective update. Front Microbiol 2017; 8:1053. https://doi.org/10.3389/fmicb.2017.01053.

[158] Rustia AJ, Paterson JS, Best G, Sokoya EM. Microbial disruption in the gut promotes cerebral endothelial dysfunction. Physiol Rep 2021; 9:e15100. https://doi.org/10.14814/phy2.15100.

[159] Luo XY, Ying JH, Wang QS. miR-25-3p ameliorates SAE by targeting the TLR4/NLRP3 axis. Metab Brain Dis 2022; 37:1803-13. https://doi.org/10.1007/s11011-022-01017-1.

[160] Park KS, Choi KH, Kim YS, Hong BS, Kim OY, Kim JH, et al. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One 2010; 5:e11334. https://doi.org/10.1371/journal.pone.0011334.

[161] Wei Y, Yang J, Wang J, Yang Y, Huang J, Gong H, et al. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis. Crit Care 2016; 20:332. https://doi.org/10.1186/s13054-016-1491-2.

[162] Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65:575-83. https://doi.org/10.1136/gutjnl-2015-309728.

[163] Li Z, Zhang F, Sun M, Liu J, Zhao L, Liu S, et al. The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy. PeerJ 2023; 11:e15122. https://doi.org/10.7717/peerj.15122.

[164] Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003; 9:125-34. https://doi.org/10.1007/BF03402177.

[165] Zhu SZ, Huang WP, Huang LQ, Han YL, Han QP, Zhu GF, et al. Huperzine a protects sepsis associated encephalopathy by promoting the deficient cholinergic nervous function. Neurosci Lett 2016; 631:70-8. https://doi.org/10.1016/j.neulet.2016.07.009.

[166] Gonzalez-Bosch C, Boorman E, Zunszain PA, Mann GE . Short-chain fatty acids as modulators of redox signaling in health and disease. Redox Biol 2021; 47:102165. https://doi.org/10.1016/j.redox.2021.102165.

[167] Morita I, Kawamoto M, Yoshida H. Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal blood. J Chromatogr 1992; 576:334-9. https://doi.org/10.1016/0378-4347(92)80208-8.

[168] Zha X, Su S, Wu D, Zhang P, Wei Y, Fan S, Huang Q, et al. The impact of gut microbiota changes on the intestinal mucus barrier in burned mice: a study using 16S rRNA and metagenomic sequencing. Burns Trauma 2023; 11:tkad056.

[169] Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Author correction: probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 2019; 16:642. https://doi.org/10.1038/s41575-019-0199-6.

[170] Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 2018; 57:1-24. https://doi.org/10.1007/s00394-017-1445-8.

[171] Nimgampalle M, Kuna Y. Anti-Alzheimer properties of probiotic, lactobacillus plantarum MTCC 1325 in Alzheimer’s disease induced albino rats. J Clin Diagn Res 2017; 11:KC01-5. https://doi.org/10.7860/JCDR/2017/26106.10428.

[172] Hafez MM. Upregulation of intestinal mucin expression by the probiotic bacterium E. Coli Nissle 1917. Probiotics Antimicrob Proteins 2012; 4:67-77. https://doi.org/10.1007/s12602-012-9092-0.

[173] Zhang P, Wu X, Liang S, Shao X, Wang Q, Chen R, et al. A dynamic mouse peptidome landscape reveals probiotic modulation of the gut-brain axis. Sci Signal 2020; 13:eabb0443. https://doi.org/10.1126/scisignal.abb0443.

[174] Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS, et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 2017; 548:407-12. https://doi.org/10.1038/nature23480.

[175] Bassetti M, Righi E, Ansaldi F, Merelli M, Trucchi C, De Pascale G, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 2014; 40:839-45. https://doi.org/10.1007/s00134-014-3310-z.

[176] Han Q, Bai Y, Zhou C, Dong B, Li Y, Luo N, et al. Effect of molecular hydrogen treatment on sepsis-associated encephalopathy in mice based on gut microbiota. CNS Neurosci Ther 2023; 29:633-45. https://doi.org/10.1111/cns.14043.

[177] Luan F, Zhou Y, Ma X, Li Y, Peng Y, Jia X, et al. Gut microbiota composition and changes in patients with sepsis: potential markers for predicting survival. BMC Microbiol 2024; 24:45. https://doi.org/10.1186/s12866-024-03188-6.

[178] Valdes-Duque BE, Giraldo-Giraldo NA, Jaillier-Ramirez AM, Giraldo-Villa A, Acevedo-Castano I, Yepes-Molina MA, et al. Stool short-chain fatty acids in critically ill patients with sepsis. J Am Coll Nutr 2020; 39:706-12. https://doi.org/10.1080/07315724.2020.1727379.

[179] Weng J, Wu H, Xu Z, Xi H, Chen C, Chen D, et al. The role of propionic acid at diagnosis predicts mortality in patients with septic shock. J Crit Care 2018; 43:95-101. https://doi.org/10.1016/j.jcrc.2017.08.009.

[180] Arnold MJ. Surviving sepsis: updated guidelines from the Society of Critical Care Medicine. Am Fam Physician 2022; 106:589-90.

[181] Kotani Y, Ryan N, Udy AA, Fujii T. Haemodynamic management of septic shock. Burns Trauma 2025; 13:tkae081.

[182] Arapis A, Panagiotopoulos D, Giamarellos-Bourboulis EJ. Recent advances of precision immunotherapy in sepsis. Burns Trauma 2025; 13:tkaf001.

[183] Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, et al. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. Elife 2024; 13:RP87458. https://doi.org/10.7554/eLife.87458.3.

[184] Tan YQ, Wang YN, Feng HY, Guo ZY, Li X, Nie XL, et al. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling. Free Radic Biol Med 2022; 184:30-41. https://doi.org/10.1016/j.freeradbiomed.2022.03.025.

[185] Salminen A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota. J Mol Med (Berl) 2023; 101:201-22. https://doi.org/10.1007/s00109-023-02289-5.

[186] Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 2024; 9:37. https://doi.org/10.1038/s41392-024-01743-1.

[187] Sun J, Zhang Y, Kong Y, Ye T, Yu Q, Kumaran Satyanarayanan S, et al. Microbiota-derived metabolite indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice. Brain Behav Immun 2022; 106:76-88. https://doi.org/10.1016/j.bbi.2022.08.003.

[188] Pan S, Zhang Y, Ye T, Kong Y, Cui X, Yuan S, et al. A high-tryptophan diet alleviated cognitive impairment and neuroinflammation in APP/PS1 mice through activating aryl hydrocarbon receptor via the regulation of gut microbiota. Mol Nutr Food Res 2024; 68:e2300601. https://doi.org/10.1002/mnfr.202300601.

[189] Xu Y, Shen B, Pan X, Liu C, Wang Y, Chen X, et al. Palmatine ameliorated lipopolysaccharide-induced sepsis-associated encephalopathy mice by regulating the microbiota-gut-brain axis. Phytomedicine 2024; 124:155307. https://doi.org/10.1016/j.phymed.2023.155307.